Researchers find improved method for treating rare, aggressive, pregnancy-related cancer
PORTLAND, Ore. – A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.
Scientists led by Olena Taratula, a nanomedicine researcher at Oregon State University, have found a way to better ensure the drug used to combat the disease reaches tumor cells without damaging healthy tissue.
Findings of the study into choriocarcinoma, which occurs in the United States at a rate of about four cases per 100,000 pregnancies, ...














